Literature DB >> 33824922

Rare and undiagnosed liver diseases: challenges and opportunities.

Luca Fabris1,2,3, Mario Strazzabosco3.   

Abstract

Entities:  

Year:  2021        PMID： 33824922      PMCID： PMC7838528          DOI： 10.21037/tgh-2020-05

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  9 in total

Review 1.  The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.

Authors:  Tobias J Weismüller; Jochen Wedemeyer; Stefan Kubicka; Christian P Strassburg; Michael P Manns
Journal:  J Hepatol       Date:  2008-02-11       Impact factor: 25.083

Review 2.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 3.  Value-based care in hepatology.

Authors:  Mario Strazzabosco; John I Allen; Elizabeth O Teisberg
Journal:  Hepatology       Date:  2017-05       Impact factor: 17.425

Review 4.  Hepatoblastoma: current knowledge and promises from preclinical studies.

Authors:  Diego F Calvisi; Antonio Solinas
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 5.  The National Institutes of Health undiagnosed diseases program.

Authors:  Cynthia J Tifft; David R Adams
Journal:  Curr Opin Pediatr       Date:  2014-12       Impact factor: 2.856

Review 6.  Genome editing technologies to treat rare liver diseases.

Authors:  Marta Trevisan; Giulia Masi; Giorgio Palù
Journal:  Transl Gastroenterol Hepatol       Date:  2020-04-05

Review 7.  Inherited iron overload disorders.

Authors:  Alberto Piperno; Sara Pelucchi; Raffaella Mariani
Journal:  Transl Gastroenterol Hepatol       Date:  2020-04-05

Review 8.  Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group.

Authors:  Trevor Richter; Sandra Nestler-Parr; Robert Babela; Zeba M Khan; Theresa Tesoro; Elizabeth Molsen; Dyfrig A Hughes
Journal:  Value Health       Date:  2015-08-18       Impact factor: 5.725

Review 9.  Access to care in rare liver diseases: New challenges and new opportunities.

Authors:  David E J Jones; Ekkehard Sturm; Ansgar W Lohse
Journal:  J Hepatol       Date:  2017-11-04       Impact factor: 25.083
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.